News
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Bright reds and yellows aren’t just eye candy—they’re behavioral nudges engineered to make ultra-processed foods irresistible ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
One San Francisco-based company aims to find a sustainable alternative by creating plant-based salmon, and with its recent ...
Georgia's congressional delegation is advocating for FDA reconsideration of the drug elamipretide for Hope Filchak.
The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat a rare inherited disorder, citing manufacturing concerns, the company said ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care The Big Story Senate panel clears ...
Apeel Sciences was founded in 2012 by CEO James Rogers. He received two grants from the Bill & Melinda Gates Foundation, which totaled less than $1.1 million. Since then, Apeel has reportedly been ...
It’s frightening,” said Committee Chair JoCasta Zamarripa during a May 20 renewal hearing for Rama Foods, where the THC ...
Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.
Ultragenyx Pharmaceutical said federal regulators have issued a complete response letter to its application for a metabolic disorder treatment that may delay the potential approval to 2026.
Exporting counterfeit medicines is a cruel business that robs ill people of any hope for relief. Cancer patients unknowingly using fake Keytruda would have no chance of improvement with their terminal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results